HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Bin Yang Selected Research

shanzha

1/2019Effects and mechanisms of Danshen-Shanzha herb-pair for atherosclerosis treatment using network pharmacology and experimental pharmacology.
6/2013[Experimental study on anti-atherosclerotic effect of compatibility of active components of danshen and shanzha].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Bin Yang Research Topics

Disease

215Neoplasms (Cancer)
10/2022 - 09/2002
65Inflammation (Inflammations)
10/2022 - 03/2001
48Infections
07/2022 - 06/2004
36Neoplasm Metastasis (Metastasis)
06/2022 - 03/2003
30Hepatocellular Carcinoma (Hepatoma)
01/2022 - 06/2003
28Reperfusion Injury
05/2021 - 11/2005
26Fibrosis (Cirrhosis)
12/2022 - 02/2001
24Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 04/2004
21Wounds and Injuries (Trauma)
06/2021 - 01/2007
20Syphilis
01/2022 - 12/2010
18Breast Neoplasms (Breast Cancer)
07/2022 - 09/2008
18Prostatic Neoplasms (Prostate Cancer)
05/2022 - 01/2011
18Pain (Aches)
04/2022 - 10/2003
17Body Weight (Weight, Body)
09/2020 - 10/2013
16COVID-19
01/2022 - 01/2020
16Ischemia
01/2021 - 05/2006
15Carcinoma (Carcinomatosis)
08/2022 - 03/2003
14Rheumatoid Arthritis
01/2022 - 11/2011
14Stroke (Strokes)
01/2022 - 08/2012
13Carcinogenesis
07/2019 - 10/2006
12Stomach Neoplasms (Stomach Cancer)
09/2022 - 10/2006
12Lung Neoplasms (Lung Cancer)
01/2022 - 06/2015
12Pathologic Constriction (Stenosis)
01/2022 - 11/2010
12Cardiovascular Diseases (Cardiovascular Disease)
12/2021 - 06/2009
12Obesity
11/2021 - 07/2007
12Systemic Lupus Erythematosus (Libman-Sacks Disease)
08/2021 - 03/2011
11Chronic Hepatitis B
06/2022 - 01/2013
11Hypoxia (Hypoxemia)
01/2022 - 04/2008
11Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2022 - 01/2019
11Uterine Cervical Neoplasms (Cancer of the Cervix)
04/2021 - 10/2006
11Disease Progression
01/2021 - 10/2011
10Type 2 Diabetes Mellitus (MODY)
05/2022 - 04/2007
10Renal Cell Carcinoma (Grawitz Tumor)
05/2022 - 12/2012
10Atherosclerosis
02/2022 - 06/2013
10Ischemic Stroke
01/2022 - 01/2016
10Ovarian Neoplasms (Ovarian Cancer)
01/2022 - 07/2008
10Glioma (Gliomas)
01/2019 - 01/2012
9Insulin Resistance
05/2022 - 11/2008
9Necrosis
02/2022 - 06/2011
9Brain Ischemia (Cerebral Ischemia)
01/2022 - 10/2011
9Squamous Cell Carcinoma (Epidermoid Carcinoma)
01/2022 - 01/2008
9Myocardial Infarction
02/2021 - 08/2012
8Autoimmune Diseases (Autoimmune Disease)
02/2022 - 02/2014
8Myopia
01/2022 - 03/2003
8Sexually Transmitted Diseases (Sexually Transmitted Disease)
01/2022 - 01/2011
8Atrophy
01/2022 - 02/2001
8Liver Neoplasms (Liver Cancer)
01/2019 - 11/2013
7Hemorrhage
04/2022 - 07/2007
7Coronary Artery Disease (Coronary Atherosclerosis)
02/2022 - 01/2018
7Pancreatic Neoplasms (Pancreatic Cancer)
01/2022 - 09/2012

Drug/Important Bio-Agent (IBA)

85Proteins (Proteins, Gene)FDA Link
10/2022 - 02/2001
60Biomarkers (Surrogate Marker)IBA
07/2022 - 04/2006
39Pharmaceutical PreparationsIBA
06/2022 - 05/2006
32MicroRNAs (MicroRNA)IBA
12/2022 - 03/2011
28Messenger RNA (mRNA)IBA
04/2022 - 02/2001
25DNA (Deoxyribonucleic Acid)IBA
12/2021 - 03/2001
24Biological ProductsIBA
01/2022 - 10/2007
23Long Noncoding RNAIBA
09/2022 - 09/2017
23CytokinesIBA
06/2022 - 02/2015
23Caspase 3 (Caspase-3)IBA
04/2022 - 03/2001
16RNA (Ribonucleic Acid)IBA
12/2022 - 06/2008
16Interleukin-6 (Interleukin 6)IBA
10/2022 - 01/2014
16Small Interfering RNA (siRNA)IBA
01/2021 - 08/2012
15EnzymesIBA
01/2022 - 10/2002
13Peptides (Polypeptides)IBA
10/2022 - 12/2012
13LipidsIBA
10/2022 - 06/2009
12Doxorubicin (Adriamycin)FDA LinkGeneric
11/2021 - 03/2014
11AcidsIBA
09/2021 - 11/2008
10Glucose (Dextrose)FDA LinkGeneric
09/2022 - 06/2009
10Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2022 - 04/2010
10Therapeutic UsesIBA
01/2022 - 09/2013
10AntigensIBA
01/2021 - 11/2007
9CollagenIBA
10/2022 - 06/2003
9Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2022 - 03/2003
9C-Reactive ProteinIBA
01/2022 - 08/2011
9Nucleic AcidsIBA
01/2022 - 06/2012
9ProdrugsIBA
03/2021 - 07/2018
9Hormones (Hormone)IBA
01/2021 - 12/2007
8Immunoglobulin G (IgG)IBA
09/2022 - 10/2017
8Monoclonal AntibodiesIBA
09/2022 - 06/2004
8Complement System Proteins (Complement)IBA
02/2022 - 04/2004
8CholesterolIBA
02/2022 - 06/2011
8AntioxidantsIBA
10/2021 - 10/2006
7HMGB1 Protein (HMG1)IBA
02/2022 - 10/2014
7Oxygen (Dioxygen)IBA
01/2022 - 10/2014

Therapy/Procedure

99Therapeutics
10/2022 - 07/2007
36Drug Therapy (Chemotherapy)
06/2022 - 03/2010
11Lasers (Laser)
07/2022 - 04/2013
10Kidney Transplantation
01/2022 - 01/2008
10Laser In Situ Keratomileusis (LASIK)
07/2013 - 03/2003
9Immunotherapy
01/2022 - 10/2016
9Transplantation
01/2022 - 07/2007
9Precision Medicine
11/2021 - 01/2015
8Stents
05/2022 - 10/2011
8Condoms (Condom)
01/2022 - 01/2011
8Radiotherapy
11/2021 - 04/2016
8Aftercare (After-Treatment)
01/2021 - 07/2009
7Self-Testing
01/2022 - 01/2018
7Photochemotherapy (Photodynamic Therapy)
01/2022 - 11/2018
7Prostatectomy (Retropubic Prostatectomy)
06/2021 - 01/2013